RE: Serum phospholipid fatty acids and prostate cancer risk in the SELECT trial
- PMID: 24685923
- PMCID: PMC4318937
- DOI: 10.1093/jnci/dju023
RE: Serum phospholipid fatty acids and prostate cancer risk in the SELECT trial
Comment in
-
Response.J Natl Cancer Inst. 2014 Apr;106(4):dju021. doi: 10.1093/jnci/dju021. Epub 2014 Mar 31. J Natl Cancer Inst. 2014. PMID: 24685927 No abstract available.
Comment on
-
Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.J Natl Cancer Inst. 2013 Aug 7;105(15):1132-41. doi: 10.1093/jnci/djt174. Epub 2013 Jul 10. J Natl Cancer Inst. 2013. PMID: 23843441 Free PMC article. Clinical Trial.
References
-
- Aronson WJ, Glaspy JA, Reddy ST, et al. Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer. Urology. 2001;58(2):283–288. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources